Abstract
Hip fractures are a major cause of disability, impairment and death in elderly people. It has been reported that bisphosphonates significantly reduce the risk of hip fracture among elderly women with confirmed osteoporosis but not among elderly women selected primarily on the basis of risk factors other than low bone mineral density. External hip protectors have been developed as a measure of reducing the impact of the fall and thereby the chance of hip fractures in such high risk people. The results of 14 randomized controlled trials for the prevention of hip fractures by using hip protectors have been reported until 2004. However, Cochrane review of hip protectors has concluded that their effectiveness is uncertain. Although further research is required with different conditions, the most important issue of hip protectors is the low adherence rate.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
